Single cycle structure-based humanization of an anti-nerve growth factor therapeutic antibody.
Most forms of chronic pain are inadequately treated by present therapeutic options. Compelling evidence has accumulated, demonstrating that Nerve Growth Factor (NGF) is a key modulator of inflammatory and nociceptive responses, and is a promising target for the treatment of human pathologies linked...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Public Library of Science (PLoS)
2012
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/863bba9b7db841b1a0914d87b29bdf05 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|